Literature DB >> 1371789

Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies.

R C Monteiro1, M D Cooper, H Kubagawa.   

Abstract

Fc alpha receptors (Fc alpha R) were isolated from a human monocytic cell line and used to raise four mAb with receptor specificity. The antibodies were used to identify the types of white blood cells that express Fc alpha R and the molecular heterogeneity of the receptor molecules. Nonpolymorphic epitopes, outside of the Fc alpha-binding site, were recognized only on blood cells of granulocyte and monocyte/macrophage lineages. The molecules identified, both by the antibodies and by the IgA ligand, were glycoproteins ranging in relative molecular mass from 55 to 75 kDa. However, one antibody detected a subpopulation of Fc alpha R molecules characterized by relatively restricted size heterogeneity. A complex glycosylation pattern was revealed by the resolution of discrete 32- and 36-kDa molecular species after removal of N-linked oligosaccharides and by evidence for O-linked carbohydrate moieties on at least a portion of the Fc alpha R molecules. In biosynthetic studies, all four anti-Fc alpha R antibodies and the IgA ligand bound a single 32-kDa core protein present in tunicamycin-treated cells, and the exceptional antibody again recognized molecules with relatively restricted glycosylation in the nontreated cells. These antibodies and native IgA ligands thus provide complementary reagents for definition of the complex structure and function of Fc alpha R in systemic IgA antibody responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Ectodomain shedding of Fcalpha receptor is mediated by ADAM10 and ADAM17.

Authors:  Min Peng; Sha Guo; Na Yin; Jing Xue; Lian Shen; Qing Zhao; Wei Zhang
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 2.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

Review 3.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

4.  Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals.

Authors:  R C Monteiro; R W Hostoffer; M D Cooper; J R Bonner; G L Gartland; H Kubagawa
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Recombinant human IgA expressed in insect cells.

Authors:  L Carayannopoulos; E E Max; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

6.  Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils.

Authors:  T Kobayashi; K Yamamoto; N Sugita; A B van Spriel; S Kaneko; J G van de Winkel; H Yoshie
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation.

Authors:  C Patry; A Herbelin; A Lehuen; J F Bach; R C Monteiro
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

8.  Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils.

Authors:  R J Pleass; P D Andrews; M A Kerr; J M Woof
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

9.  IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells.

Authors:  S Toyabe; Y Kuwano; K Takeda; M Uchiyama; T Abo
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor.

Authors:  Kaoru Kikuno; Dong-Won Kang; Kazuki Tahara; Ikuko Torii; Homare M Kubagawa; Kang Jey Ho; Lucie Baudino; Naoto Nishizaki; Akira Shibuya; Hiromi Kubagawa
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.